Charles Schwab Investment Management Inc Eton Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,239 shares of ETON stock, worth $143,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,239
Previous 13,239
-0.0%
Holding current value
$143,643
Previous $43,000
83.72%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
51Shares Held
9.44MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$30.2 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$11.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$10.8 Million0.36% of portfolio
-
Westside Investment Management, Inc.619KShares$6.71 Million0.79% of portfolio
-
Acuitas Investments, LLC580KShares$6.29 Million1.66% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $274M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...